Regulus: Q4 Earnings Snapshot
In this article:
SAN DIEGO (AP) — SAN DIEGO (AP) — Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $6.8 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 40 cents.
For the year, the company reported a loss of $28.3 million, or $1.86 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS
